<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
  <mods>
    <titleInfo>
      <title>Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells</title>
    </titleInfo>
    <name type="personnal">
      <namePart type="family">Jaimovich</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Mattei</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Liberona</namePart>
      <namePart type="given">J. L.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Cardenas</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Estrada</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Barbier</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Debitus</namePart>
      <namePart type="given">Cécile</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Laurent</namePart>
      <namePart type="given">Dominique</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Molgo</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <physicalDescription>
      <internetMediaType>text/pdf</internetMediaType>
      <digitalOrigin>reformatted digital</digitalOrigin>
      <reformattingQuality>access</reformattingQuality>
    </physicalDescription>
    <abstract>Xestospongin B, a macrocyclic bis-1-oxaquinolizidine alkaloid extracted from the marine sponge Xestospongia exigua, was highly purified and tested for its ability to block inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release. In a concentration-dependent manner xestospongin B displaced [H-3]IP3 from both rat cerebellar membranes and rat skeletal myotube homogenates with an EC50 of 44.6 +/- 1.1 mu M and 27.4 +/- 1.1 mu M, respectively. Xestospongin B, depending on the dose, suppressed bradykinin-induced Ca2+ signals in neuroblastoma (NG108-15) cells, and also selectively blocked the slow intracellular Ca2+ signal induced by membrane depolarization with high external K+ (47mM) in rat skeletal myotubes. This slow Ca2+ signal is unrelated to muscle contraction, and involves IP3 receptors. In highly purified isolated nuclei from rat skeletal myotubes, Xestospongin B reduced, or suppressed IP3-induced Ca2+ oscillations with an EC50 = 18.9 +/- 1.35 mu M. In rat my rotubes exposed to a Ca2+-free medium, Xestospongin B neither depleted sarcoplasmic reticulum Ca2+ stores, nor modified thapsigargin action and did not affect capacitative Ca2+ entry after thapsigargin-induced depletion of Ca2+ stores. Ca2+-ATPase activity measured in skeletal myrotube homogenates remained unaffected by Xestospongin B. It is concluded that xestospongin B is an effective cell-permeant. competitive inhibitor of IP3 receptors in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.</abstract>
    <targetAudience authority="marctarget">specialized</targetAudience>
    <subject authority="local">
      <topic>INVERTEBRE AQUATIQUE</topic>
      <topic>SUBSTANCE NATURELLE</topic>
      <topic>ALCALOIDE</topic>
      <topic>STRUCTURE CHIMIQUE</topic>
      <topic>ACTIVITE BIOLOGIQUE</topic>
      <topic>INTERET PHARMACOLOGIQUE</topic>
      <topic>CULTURE CELLULAIRE</topic>
      <topic>TEST</topic>
    </subject>
    <subject>
      <topic>XESTOSPONGIN B</topic>
      <topic>EPONGE</topic>
    </subject>
    <subject>
      <topic>xestospongin B</topic>
      <topic>inositol 1,4,5 trisphosphate</topic>
      <topic>intracellular Ca2+ signals</topic>
      <topic>bradykinin</topic>
      <topic>neuroblastoma NG108 15 cell</topic>
      <topic>rat skeletal myotubes</topic>
      <topic>cerebellar membranes</topic>
      <topic>isolated myonuclei</topic>
      <topic>calcium ATPase</topic>
    </subject>
    <subject authority="local">
      <geographic>NOUVELLE CALEDONIE</geographic>
    </subject>
    <classification authority="local">035SUBSAN02</classification>
    <relatedItem type="host">
      <titleInfo>
        <title>Febs Letters</title>
      </titleInfo>
      <part>
        <detail type="volume">
          <number>579</number>
        </detail>
        <detail type="volume">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <list> 2051-2057</list>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">0014-5793</identifier>
    </relatedItem>
    <identifier type="uri">https://www.documentation.ird.fr/hor/fdi:010038253</identifier>
    <identifier type="doi">10.1016/j.febslet.2005.02.053</identifier>
    <identifier type="issn">0014-5793</identifier>
    <location>
      <shelfLocator>[F B010038253]</shelfLocator>
      <url usage="primary display" access="object in context">https://www.documentation.ird.fr/hor/fdi:010038253</url>
      <url access="row object">https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-12/010038253.pdf</url>
    </location>
    <recordInfo>
      <recordContentSource>IRD - Base Horizon / Pleins textes</recordContentSource>
      <recordCreationDate encoding="w3cdtf">2006-03-29</recordCreationDate>
      <recordChangeDate encoding="w3cdtf">2024-12-18</recordChangeDate>
      <recordIdentifier>fdi:010038253</recordIdentifier>
      <languageOfCataloging>
        <languageTerm authority="iso639-2b">fre</languageTerm>
      </languageOfCataloging>
    </recordInfo>
  </mods>
</modsCollection>
